ArticleBMJ public health2024
Factors affecting patients on antiretroviral therapy lost to follow-up in Asunafo South District of Ahafo Region, Ghana: a cross-sectional study.
Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The loss to follow-up of participants excluded from the NAMSAL trial: a retrospective cohort study.Scientific reports · 2025Article
- Identifying risk factors for loss to follow-up in adults living with HIV in a high-burden district in Ghana.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Introduction: Despite the increased and effective programme coverage for antiretroviral therapy (ART), a considerable proportion of individuals receiving ART discontinue medication at different stages of their treatment pathway. In sub-Saharan Africa, approximately half of individuals who test positive for HIV are lost to follow-up (LTFU). This study was set out to answer the following question 'What are the factors that affect patients on ART loss to follow-up in Asunafo South District of Ghana?'. Methods: Cross-sectional study design with systematic random sampling was employed to select 620 HIV patients on ART. Stata V.17.0 was used to analyse the data. A cox-proportional hazard regression was fitted in order to determine the predictor variables. Variables for the multivariable regression model were chosen by entering the outcome variable (LTFU) and explanatory variables into the model. Finally, the association between the explanatory and outcome factors was determined using the adjusted HRs and their associated 95% CI was considered. Results: A total of 600 respondents were used for the final analysis after data cleaning. Patients who began ART at age 41 years or older had a significantly lower chance of being LTFU than those who began ART at age 35 or less (adjusted HR (aHR)=0.34, 95% CI 0.13 to 0.84). Furthermore, patients who started ART with a primary education had 1.68-fold increased risk of LTFU compared with patients with no education (aHR=1.68; 95% CI 0.83 to 3.43). In addition, patients in rural locations had a 2.65-fold higher likelihood of being LTFU than patients in urban areas (aHR=2.65, 95% CI 1.29 to 5.44). The main reasons for missing ART appointments among patients included walking long distance to clinic, cost of transportation, fear of scolding from clinic staff, stigma and erratic supply of antiretrovirals. Conclusion: All clinicians should consider the risk factors that have been identified when providing ART services and counselling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.